{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-24-007479","form_type":"8-K/A","ticker":"ZIVO","cik":"0001101026","company_name":"Zivo Bioscience, Inc.","filed_at":"2024-06-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.284729+00:00","generated_at":"2026-06-01T05:28:19.945500+00:00","sec_items":["1.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Zivo Bioscience amends 8-K to correct date typo in director stock award from 2023","bullets":["Corrects date in Item 1.01 from erroneous date to December 29, 2023.","Board approved 261,619 shares to three non-employee directors for unpaid 2023 fees of $172,670.","Shares issued at $1.20 per share (Dec 29, 2023 close), grossed up for taxes at 45%.","Directors Cornell (95k), Masterson (85k), Maggiore (82k) accepted grants on June 5, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-24-007479","json":"https://secwatch.observer/filing/0001654954-24-007479.json","markdown":"https://secwatch.observer/filing/0001654954-24-007479.md","text":"https://secwatch.observer/filing/0001654954-24-007479.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1101026/000165495424007479/0001654954-24-007479-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1101026/000165495424007479/zivo_8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T05:28:19.945500+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}